Gene · 9401
Papers1,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA binding contributes to dominant-negative effects of a catalytically inactive RecQ4-family helicase. | Nucleic Acids Res | 2026 | 42755368 | PubTator, text mining | PubMed |
| MCM10 and RECQL4 have cooperative and redundant roles in activating the CMG helicase during the replication initiation. | Genes Dev | 2026 | 42697600 | PubTator, text mining | PubMed |
| Retraction Note: TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway. | World J Surg Oncol | 2026 | 42649497 | PubTator, text mining | PubMed |
| Identification of a Pathogenic RECQL4 1.6-kb Deletion-Insertion in a Neonate with Atypical Skeletal Phenotype of Baller-Gerold Syndrome Using Rapid Whole-Genome Sequencing. | Ann Lab Med | 2026 | 42608969 | PubTator, text mining | PubMed |
| Distinct Mitochondrial Central Dogma Gene Expression in the Buffalo Brain: A Comparative Transcriptomic Study with Metabolically Active Organs. | Mol Neurobiol | 2026 | 42606642 | PubTator, text mining | PubMed |
| [WRN and Other RecQ Helicases in Life Cycles of Viruses]. | Mol Biol (Mosk) | 2026 | 42599232 | PubTator, text mining | PubMed |
| Integrative Network-Based Transcriptomic Analysis Identifies Niclosamide as a Candidate Repositioned Drug for Breast Cancer. | Breast Cancer (Dove Med Press) | 2026 | 42524299 | PubTator, text mining | PubMed |
| RECQ4 arginine methylation suppresses single-stranded DNA gap accumulation at replication forks. | Nucleic Acids Res | 2026 | 42363758 | PubTator, text mining | PubMed |
| Case Report: A case of Rothmund-Thomson syndrome-like phenotype with an ANAPC1 variant of uncertain significance and observed hair improvement. | Front Med (Lausanne) | 2026 | 42210937 | PubTator, text mining | PubMed |
| A novel mitochondrial-related signature to decode tumor immunity and predict survival in chromophobe renal cell carcinoma. | Immunobiology | 2026 | 42155297 | PubTator, text mining | PubMed |
| Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib. | Immunotargets Ther | 2026 | 41878019 | PubTator, text mining | PubMed |
| Minute amounts of helicase-deficient truncated RECQL4 are sufficient for DNA replication. | EMBO Rep | 2026 | 41807760 | PubTator, text mining | PubMed |
| Shuttling of RecQ helicase HIM-6 coordinates iterative cycle of unwinding, pulling, and backsliding. | Nucleic Acids Res | 2026 | 41805131 | PubTator, text mining | PubMed |
| Unmanipulated bone marrow infusion without conditioning can rescue RECQL4 -/- severe combined immunodeficiency. | J Hum Immun | 2026 | 41798738 | PubTator, text mining | PubMed |
| Integrative Genomic Profiling of Pediatric Solid Tumors Reveals Clinically Relevant Variants and Chromosomal Arm Aneuploidies Signatures. | Cancer Med | 2026 | 41776381 | PubTator, text mining | PubMed |
| Computational Insights into SIRT1: Elucidating Mutational Impact on SIRT1-RECQL4 Structural Dynamics. | Cell Biochem Biophys | 2026 | 41776022 | PubTator, text mining | PubMed |
| Detection of germline variants in human population chronically exposed to high level natural background radiation in Kerala coast. | Genes Environ | 2026 | 41761368 | PubTator, text mining | PubMed |
| Adjuvant Larotrectinib in a Resected Secretory Carcinoma-Like Lung Adenocarcinoma Harboring EML4-NTRK3 Fusion: Case Report. | JTO Clin Res Rep | 2026 | 41756181 | PubTator, text mining | PubMed |
| Genomic Insights into Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2026 | 41749812 | PubTator, text mining | PubMed |
| Neuroendocrine-associated epigenetic factors in cellular senescence: mechanisms and therapeutic implications. | Biogerontology | 2026 | 41746442 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9401/papers